BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Reinisch W, Chowers Y, Danese S, Dignass A, Gomollón F, Nielsen OH, Lakatos PL, Lees CW, Lindgren S, Lukas M, Mantzaris GJ, Michetti P, Moum B, Peyrin-Biroulet L, Toruner M, van der Woude J, Weiss G, Stoevelaar H. The management of iron deficiency in inflammatory bowel disease--an online tool developed by the RAND/UCLA appropriateness method. Aliment Pharmacol Ther 2013;38:1109-18. [PMID: 24099472 DOI: 10.1111/apt.12493] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Nielsen OH, Soendergaard C, Vikner ME, Weiss G. Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease. Nutrients 2018;10:E82. [PMID: 29342861 DOI: 10.3390/nu10010082] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
2 Nielsen OH, Ainsworth M, Coskun M, Weiss G. Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review. Medicine (Baltimore) 2015;94:e963. [PMID: 26061331 DOI: 10.1097/MD.0000000000000963] [Cited by in Crossref: 43] [Cited by in F6Publishing: 19] [Article Influence: 7.2] [Reference Citation Analysis]
3 Abitbol V, Borderie D, Polin V, Maksimovic F, Sarfati G, Esch A, Tabouret T, Dhooge M, Dreanic J, Perkins G. Diagnosis of Iron Deficiency in Inflammatory Bowel Disease by Transferrin Receptor-Ferritin Index. Medicine (Baltimore). 2015;94:e1011. [PMID: 26131803 DOI: 10.1097/md.0000000000001011] [Cited by in Crossref: 24] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
4 Høivik ML, Reinisch W, Cvancarova M, Moum B; IBSEN study group. Anaemia in inflammatory bowel disease: a population-based 10-year follow-up. Aliment Pharmacol Ther 2014;39:69-76. [PMID: 24172277 DOI: 10.1111/apt.12541] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.5] [Reference Citation Analysis]
5 Reinisch W, Altorjay I, Zsigmond F, Primas C, Vogelsang H, Novacek G, Reinisch S, Thomsen LL. A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease. Scand J Gastroenterol 2015;50:1226-33. [PMID: 25900645 DOI: 10.3109/00365521.2015.1031168] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
6 Goyal A, Zheng Y, Albenberg LG, Stoner NL, Hart L, Alkhouri R, Hampson K, Ali S, Cho-Dorado M, Goyal RK, Grossman A. Anemia in Children With Inflammatory Bowel Disease: A Position Paper by the IBD Committee of the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2020;71:563-82. [PMID: 32947565 DOI: 10.1097/MPG.0000000000002885] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
7 Glaspy JA, Lim-Watson MZ, Libre MA, Karkare SS, Hadker N, Bajic-Lucas A, Strauss WE, Dahl NV. Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia: A Systematic Literature Review. Ther Clin Risk Manag 2020;16:245-59. [PMID: 32308402 DOI: 10.2147/TCRM.S243462] [Cited by in Crossref: 21] [Cited by in F6Publishing: 6] [Article Influence: 21.0] [Reference Citation Analysis]
8 Howaldt S, Domènech E, Martinez N, Schmidt C, Bokemeyer B. Long-Term Effectiveness of Oral Ferric Maltol vs Intravenous Ferric Carboxymaltose for the Treatment of Iron-Deficiency Anemia in Patients With Inflammatory Bowel Disease: A Randomized Controlled Noninferiority Trial. Inflamm Bowel Dis 2021:izab073. [PMID: 33988236 DOI: 10.1093/ibd/izab073] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Rogler G, Vavricka S. Anemia in inflammatory bowel disease: an under-estimated problem? Front Med (Lausanne). 2014;1:58. [PMID: 25646159 DOI: 10.3389/fmed.2014.00058] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
10 Çekiç C, İpek S, Aslan F, Akpınar Z, Arabul M, Topal F, Sarıtaş Yüksel E, Alper E, Ünsal B. The effect of intravenous iron treatment on quality of life in inflammatory bowel disease patients with nonanemic iron deficiency. Gastroenterol Res Pract 2015;2015:582163. [PMID: 25691898 DOI: 10.1155/2015/582163] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ampudia-Blasco FJ, Benhamou PY, Charpentier G, Consoli A, Diamant M, Gallwitz B, Khunti K, Mathieu C, Ridderstråle M, Seufert J, Tack C, Vilsbøll T, Phan TM, Stoevelaar H. A decision support tool for appropriate glucose-lowering therapy in patients with type 2 diabetes. Diabetes Technol Ther 2015;17:194-202. [PMID: 25347226 DOI: 10.1089/dia.2014.0260] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
12 Kaniewska M, Bartnik W, Gonciarz M, Kłopocka M, Linke K, Małecka-Panas E, Radwan P, Reguła J, Rydzewska G. Iron deficiency anaemia in patients with inflammatory bowel disease: National Consultant for Gastroenterology Working Group Recommendations. Prz Gastroenterol 2014;9:259-63. [PMID: 25395998 DOI: 10.5114/pg.2014.46159] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]